
handle: 10261/384356
Adrenocortical carcinomas (ACCs) are invasive tumours arising in the adrenal cortex, and steroidogenic tumours are associated with worse prognostic outcomes. Loss-of-function mutations in sphingosine-1-phosphate lyase (SGPL1) cause primary adrenal insufficiency and as a key degradative enzyme in the sphingolipid pathway, SGPL1 also influences the balance of pro-proliferative and pro-apoptotic sphingolipids. We, therefore, hypothesized increased SGPL1 may be linked to increased disease severity in ACC.
We generated SGPL1 overexpressing H295R cells, as well as SGPL1 KO H295R cells and compared their transcriptomes by RNAseq. We used 3 biological replicates per group.
Peer reviewed
SGPL1, Sphingosine-1-phosphate lyase, http://metadata.un.org/sdg/3, Ensure healthy lives and promote well-being for all at all ages
SGPL1, Sphingosine-1-phosphate lyase, http://metadata.un.org/sdg/3, Ensure healthy lives and promote well-being for all at all ages
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
